Proteomic Analysis of Cerebrospinal Fluid from Severe COVID‐19 Patients Reveals Prognostic Biomarkers Associated with Disease Outcome
PROTEOMICS – Clinical Applications · 2026-03 · 20 (2)
DOI: 10.1002/prca.70042 ↗Kurz gefasst
Fachartikel in der Zeitschrift PROTEOMICS – Clinical Applications, online erschienen am 14.03.2026. Verfasst von Harry Alexopoulos und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece. Hauptthemen laut MEDLINE: COVID-19, Proteomics, Proteome. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
Coronavirus disease 2019 (COVID‐19) has highlighted significant neurological complications in severe cases. Cerebrospinal fluid (CSF) proteomics could reveal biomarkers related to clinical outcome among critically ill patients. Experimental Design We performed high‐resolution proteomic analyses of CSF samples from 29 intensive care unit (ICU) patients with severe COVID‐19 and 19 controls. Differentially expressed proteins and associated pathways were identified through bioinformatic and statistical analyses.
Results
Proteomic analysis identified 488 significantly altered proteins between COVID‐19 patients and controls. Proteins linked to coagulation, inflammation, and blood‐brain barrier dysfunction (e.g., SERPINC1, KNG1, PLG) were elevated in patients who survived ICU admission. Conversely, proteins associated with metabolic disruption, cellular stress, and neuroinflammation (e.g., FABP3, PDIA4) were upregulated in non‐survivors. Pathway enrichment analyses confirmed involvement of immune activation, inflammatory responses, and coagulation cascades. Conclusions and clinical relevance CSF proteomics in severe COVID‐19 patients reveals potential biomarkers predictive of patient outcomes. These findings support the involvement of systemic inflammation and blood‐brain barrier disruption in COVID‐19 pathophysiology, suggesting novel targets for personalized intervention strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.
- Institute For Bioinnovation, BSRC "A. Fleming", Vari, Attica, Greece.
- 1st Department of Intensive Care, Evangelismos Hospital, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
- Department of Neurology, General and Oncological Hospital of Kifisia, Athens, Greece.
- Department of Pathophysiology, Faculty of Medicine, National and Kapodistrian University of Athens.
- Center For Clinical, Experimental Surgery & Translational Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece.
ORCID-Profile: Harry Alexopoulos, Ioannis Trougakos
Zitieren
APA
Alexopoulos, H., Samiotaki, M., Gkogkou, E., Mavromati, S., Bitzogli, K., Panagiotou, G., Tzioufas, A., Magira, E., Kotanidou, Α., & Trougakos, I. (2026). Proteomic Analysis of Cerebrospinal Fluid from Severe COVID‐19 Patients Reveals Prognostic Biomarkers Associated with Disease Outcome. PROTEOMICS – Clinical Applications, 20(2). https://doi.org/10.1002/prca.70042
Vancouver
Alexopoulos H, Samiotaki M, Gkogkou E, Mavromati S, Bitzogli K, Panagiotou G, et al. Proteomic Analysis of Cerebrospinal Fluid from Severe COVID‐19 Patients Reveals Prognostic Biomarkers Associated with Disease Outcome. PROTEOMICS – Clinical Applications. 2026;20(2). doi:10.1002/prca.70042
BibTeX
@article{Alexopoulos2026,
author = {Alexopoulos, Harry and Samiotaki, Martina and Gkogkou, Eirini and Mavromati, Sofia and Bitzogli, Kleopatra and Panagiotou, Georgios and Tzioufas, Athanasios and Magira, Eleni and Kotanidou, Αnastasia and Trougakos, Ioannis},
title = {Proteomic Analysis of Cerebrospinal Fluid from Severe COVID‐19 Patients Reveals Prognostic Biomarkers Associated with Disease Outcome},
journal = {PROTEOMICS – Clinical Applications},
year = {2026},
volume = {20},
number = {2},
doi = {10.1002/prca.70042}
}
EUVIMED